Explain this page
Arphra AIPlain-English read on AlphaTON Capital Corp.’s valuationBusiness description
· company · SEC profileAlphaTON Capital Corp.
AlphaTON Capital Corp. is the rebranded entity formerly known as Portage Biotech Inc., a clinical-stage immuno-oncology company transitioning into a digital asset treasury model focused on accumulating and staking Toncoin (TON). AlphaTON intends to invest significantly in TON tokens, targeting a Long-Term TON treasury of approximately USâ¯$100 million.
Founded
—
IPO
Jan 02, 2002
Employees
4
HQ
Road Town
CEO
Brittany Kaiser
CFO
—
Exchange
NASDAQ
Fiscal year
—
Identifiers
· company_identifiersCIK0001095435
CUSIPG7185A136
ISINVGG7185A1369
FIGIATON US
LEI—